[A comment on the article by Taenzer, V., et al.: Intravenous cholegraphy with Chologram(R), Fortschr. Röntgenstr. 123 (1975) 414].
A comparison of the results published by Taenzer et al. shows: 1. The contrast value of the new hepatotropic substance Iotroxamid (Chologram) in man is of the same order as the previously available contrast media Bilivistan and Biligram (Ioglycamide) 2. The reputedly improved tolerance of the new substance should be confirmed in a more extensive clinical material under the stated conditions. 3. The question whether Chologram permits greater flexibility with regard to the timing of the examination must also remain open for the present.